The University of Chicago Header Logo

Connection

Richard Schilsky to BRCA1 Protein

This is a "connection" page, showing publications Richard Schilsky has written about BRCA1 Protein.
Connection Strength

0.363
  1. Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Jun; 8:e2400026.
    View in: PubMed
    Score: 0.190
  2. Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study. JCO Precis Oncol. 2023 02; 7:e2200505.
    View in: PubMed
    Score: 0.173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.